B Lian#, Z Li#, N Wu, M Li, X C, hen, H Zhang, M Gao, D Wang, X Chen, H Tian, L Si, Z Chi, X Wang, Y Lai, T Sun, Q Zhang, Y Kong, GV Long, J Guo, C CUI. Phase II clinical trial of neoadjuvant anti-PD-1 (toripalimab) combined with axitinib in resectable mucosal melanoma.,Annals of Oncology,2024 Feb;35(2):211-220

Guan Z#, Li ZW#, Yang D, Yu T, Jiang HJ, Zhang XY*, Yan S, Hou W, Sun YS*. Small arteriole sign: an imaging feature for staging T4a colon cancer,Eur Radiol,2024 Jan;34(1):444-454.

Liu J#, Wang X#, Li Z#, Gao S, Mao L, Dai J, Li C, Cui C, Chi Z, Sheng X, Lai Y, Tan Z, Lian B, Tang B, Yan X, Li S, Zhou L, Wei X, Li J, Guo J, Si L.Neoadjuvant oncolytic virus orienx010 and toripalimab in resectable acral melanoma: a phase Ib trial.,Signal Transduct Target Ther.,2024 Nov 22;9(1):318

Zhang P#, Li Z#, Li J, Li J, Zhang X, Lu Z, Sun Y, Li Y, Zhou J, Wang X, Peng Z, Shen L, Lu M.Clinicopathological features and lymph node and distant metastasis patterns in patients with gastroenteropancreatic mixed neuroendocrine-non-neuroendocrine neoplasm,Cancer Med .,10(14):4855-4863

Hu L#, Sun J#, Li Z#, Qu Z, Liu Y, Wan Q, Liu J, Ding X, Zang F, Zhang J, Yao L, Xu Y, Wang Y, Xie Y.Clinical relevance of pathogenic germline variants in mismatch repair genes in Chinese breast cancer patients.,NPJ Breast Cancer .,8(1):52

Xing X#, Shi J#, Jia Y#, Dou Y#, Li Z#, Dong B, Guo T, Cheng X, Li X, Du H, Hu Y, Jia S*, Zhang J*, Li Z*, Ji J*.Effect of neoadjuvant chemotherapy on the immune microenvironment in gastric cancer as determined by multiplex immunofluorescence and T cell receptor repertoire analysis.,J Immunother Cancer,10(3):e003984

Zhao Z#, Zhang X#, Li Z#, Gao Y, Guan X, Jiang Z, Liu Z, Yang M, Chen H, Ma X, Yang R, Lu Z, Liu H, Yang L, Wu A, Zou S, Wang X.Automated assessment of DNA ploidy, chromatin organization, and stroma fraction to predict prognosis and adjuvant therapy response in patients with stage II colorectal carcinoma,Am J Cancer Res .,11(12):6119-6132

Zijian Cao, Jia You, Yumeng Fan, Jiaying Yang, Jirui Sun, Xiuli Ma, Jinku Zhang, Zhongwu Li#, Xiang Wang#, Yuxiong Feng#. Noncanonical UPR factor CREB3L2 drives immune evasion of triple-negative breast cancer through Hedgehog pathway modulation in T cells.,Sci Adv .,2025 Jan 10;11(2):eads5434.

Tan L, Li H, Yu J, Zhou H, Wang Z, Niu Z, Li J*, Li *Z.Colorectal cancer lymph node metastasis prediction with weakly supervised transformer-based multi-instance learning.,Med Biol Eng Comput.,2023 Jun;61(6):1565-1580.

Liu Z#, Wang A#, Pu Y#, Li Z#, Xue R, Zhang C, Xiang X, E JY, Bu Z, Bai F, Ji J.Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach,Oncogene .,40(38):5705-5717

Xuesong Yang,Yan Wu, Anqiang Wang, Xiuli Ma, Kai Zhou, Ke Ji, Xin Ji, Ji Zhang, Xiaojiang Wu, Zhongwu Li*, Zhaode Bu*. Immunohistochemical characteristics and potential therapeutic regimens of hepatoid adenocarcinoma of the stomach: a study of 139 cases.,The Journal of Pathology: Clinical Research,2024 Jan;10(1):e343.

Lian S, Yang L, Feng Q, Wang P, Wang Y, Li Z.Folate-Receptor Positive Circulating Tumor Cell Is a Potential Diagnostic Marker of Prostate Cancer.,Front Oncol .,8;11:708214

Song Q, Zheng Y, Wu J, Wang S, Meng L, Yao Q, Li Z*, Lian S*.PTP4A3 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Papillary Renal Cell Carcinoma,Front Immunol,23;12:717688

PTP4a3 通过促进CHK2翻译后修饰调控肿瘤转移及免疫微环境的机制研究, 课题负责人, 2024.1.1～2026.12.31, 内蒙古自治区科学技术厅

核型、DNA倍性及肿瘤间质比在Ⅱ期结肠癌预后评估中的应用, 课题负责人, 2022.1.1～2024.12.31, 北京市卫生健康委员会

基于人工智能的结直肠癌及恶性黑色素瘤 淋巴结转移数字病理辅助诊断系统的研究, 课题负责人, 2021.1.1～2022.12.31, 北京大学